Methylene Blue: A New Hope for Cancer Tr...

Rheumatoid arthritis is not just a joint disease but a disorder of accelerated immune aging, with your immune system acting decades older than your actual age People with early joint pain already show reduced production of fresh immune cells and higher levels of inflammation, yea ... Show More

Frequent standing breaks improve heart health. Research shows it reduced blood pressure by 2 to 3 millimeters of mercury (mmHg) in postmenopausal women within 12 weeks Prolonged sitting increases cancer risk significantly. Every additional two hours of daily sitting raises overal ... Show More

DMSO is an "umbrella remedy" capable of treating a wide range of challenging ailments due to its combination of therapeutic properties (e.g., reducing inflammation, improving circulation, and reviving dying cells). It also rapidly transports substances dissolved in it through the ... Show More

In this podcast, we’re going to talk about the best-selling drug in the world: Keytruda. Keytruda helps your immune system find and kill cancer cells. Keytruda is also used for autoimmune diseases and certain infections. Unlike chemotherapy, Keytruda helps kill cancer cells witho ... Show More

Methylene Blue, C60, Mitochondrial Health - Join us in this week's podcast where we sit down with the wonderful Mike Belkowski, founder of BioLight, renowned for developing effective red light therapy panels! Mike introduces us to the concept of the "mitochondrial triad" for enha ... Show More

There are many ways that vitamin D function supports cancer prevention. Vitamin D triggers a cell to commit suicide if it’s damaged. It helps regulate cell growth and has potent anti-inflammatory properties. Vitamin D enhances almost every part of your immune system, enhances che ... Show More

The Cancer Moonshot initiative, launched under the Obama administration, was audacious by design: Supercharge cancer research to encourage innovation, with the mission “to end to cancer as we know it.” Cancer researchers avoid using the word “cure.” From studying cancer at the mo ... Show More

CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, M ... Show More

Professor Vincenzo Cerundolo tells us how research in immunology leads to the development of new cancer treatments. Immunotherapy stimulates the body's immune system, and can be a powerful treatment for cancer. The most efficient prophylactic cancer vaccine today is the vaccine a ... Show More

Lung cancer is one of the most commonly diagnosed type of cancer and so it is fitting that we start the first of our disease-specific oncology series with this diagnosis. An important component of treatment in lung cancer (and many other cancers) is the use of radiation. This wee ... Show More

Join Lebaron (Lee) Agostini and Connor Wander in our FIRST VIDEO episode! This episode is all about Cancer Biology. Lee studies experimental cancer therapies for pancreatic cancer. New cancer therapies called combination or synergystic cancer therapies use multiple drug types to ... Show More

In this week's episode, we’ll learn more about how measurable residual disease might help guide decisions about post-transplant gilteritinib maintenance in FLT3-ITD acute myeloid leukemia, or AML; how stemness contributes to chemotherapy resistance in AML; and effects of babesios ... Show More